Exparel (bupivacaine liposomal injectable suspension)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Exparel (bupivacaine liposomal injectable suspension), covering 2024-05-08 to 2024-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of the Ultrasound-guided Paravertebral Nerve Block With Liposomal Bupivacaine Versus Ropivacaine for Post-Surgical Pain After Video-Assisted Thoracoscopic Surgery [Phase 3]